SOPHiA GENETICS S.A.
General ticker "SOPH" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $269.6M (TTM average)
SOPHiA GENETICS S.A. follows the US Stock Market performance with the rate: 51.5%.
Estimated limits based on current volatility of 2.2%: low 4.87$, high 5.09$
Factors to consider:
- Total employees count: 518 as of 2021
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.90$, 6.56$]
- 2026-12-31 to 2027-12-31 estimated range: [2.63$, 6.07$]
Financial Metrics affecting the SOPH estimates:
- Positive: with PPE of -9.2 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Inventory ratio change, % of -12.04 <= -0.75
- Positive: 19.24 < Shareholder equity ratio, % of 28.84 <= 42.59
- Positive: Interest expense per share per price, % of 1.44 <= 3.31
- Positive: -4.41 < Investing cash flow per share per price, % of -3.32
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term SOPH quotes
Long-term SOPH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $62.37MM | $65.17MM | $77.27MM |
| Operating Expenses | $137.20MM | $131.74MM | $148.20MM |
| Operating Income | $-74.83MM | $-66.57MM | $-70.92MM |
| Non-Operating Income | $-3.67MM | $5.30MM | $-7.56MM |
| Interest Expense | $0.59MM | $1.91MM | $4.55MM |
| R&D Expense | $36.97MM | $34.37MM | $33.57MM |
| Income(Loss) | $-78.50MM | $-61.27MM | $-78.49MM |
| Taxes | $0.00MM | $0.00MM | $0.51MM |
| Net Income(Loss)* | $-78.98MM | $-62.49MM | $-79.00MM |
| Stockholders Equity | $151.44MM | $96.49MM | $47.15MM |
| Inventory | $6.48MM | $5.87MM | $6.35MM |
| Assets | $206.16MM | $155.31MM | $163.46MM |
| Operating Cash Flow | $-48.58MM | $-42.82MM | $-38.01MM |
| Capital expenditure | $9.23MM | $8.18MM | $0.57MM |
| Investing Cash Flow | $8.32MM | $-8.18MM | $-10.51MM |
| Financing Cash Flow | $-2.82MM | $11.59MM | $34.13MM |
| Earnings Per Share** | $-1.22 | $-0.95 | $-1.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.